Status:
COMPLETED
Male breAsT cAncer preDisposition Factor
Lead Sponsor:
Institut Claudius Regaud
Collaborating Sponsors:
Ligue contre le cancer, France
Conditions:
Breast Cancer
Eligibility:
MALE
18+ years
Brief Summary
This is a non-interventional, prospective, single-center study designed to collect and describe environmental and psychosocial data from patients with a history of male breast cancer (MBC) referenced ...
Eligibility Criteria
Inclusion
- Male patient with a personal history of breast cancer
- Age ≥ 18 years
- Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database
- Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-)
- Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation).
Exclusion
- 1\. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Key Trial Info
Start Date :
February 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 6 2025
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT06219187
Start Date
February 8 2024
End Date
February 6 2025
Last Update
February 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCT-O
Toulouse, France